{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:25:38Z","timestamp":1773833138973,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Health Innovation Centre of Singapore","award":["I2D-1612150"],"award-info":[{"award-number":["I2D-1612150"]}]},{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","award":["ING-000101 BIO"],"award-info":[{"award-number":["ING-000101 BIO"]}],"id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Management of acute decompensated heart failure (ADHF) requires disparate treatments depending on the state of systemic\/peripheral perfusion and the presence\/absence of expanded body\u2013fluid volumes. There is an unmet need for therapeutics that differentially treat each aspect. Atrial natriuretic peptide (ANP) plays an important role in blood pressure and volume regulation. We investigate for the first time the integrated haemodynamic, endocrine and renal effects of human ANP analogues, modified for exclusive vasodilatory (ANP-DRD) or diuretic (ANP-DGD) activities, in normal health and experimental ADHF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We compared the effects of incremental infusions of ANP analogues ANP-DRD and ANP-DGD with native ANP, in normal (n\u2009=\u20098) and ADHF (n\u2009=\u20098) sheep. ANP-DRD administration increased plasma cyclic guanosine monophosphate (cGMP) in association with dose-dependent reductions in arterial pressure in normal and heart failure (HF) sheep similarly to ANP responses. In contrast to ANP, which in HF produced a diuresis\/natriuresis, this analogue was without significant renal effect. Conversely, ANP-DGD induced marked stepwise increases in urinary cGMP, urine volume, and sodium excretion in HF comparable to ANP, but without accompanying vasodilatory effects. All peptides increased packed cell volume relative to control in both states, and in HF, decreased left atrial pressure. In response to ANP-DRD-induced blood pressure reductions, plasma renin activity rose compared to control only during the high dose in normals, and not at all in HF\u2014suggesting relative renin inhibition, with no increase in aldosterone in either state, whereas renin and aldosterone were both significantly reduced by ANP-DGD in HF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These ANP analogues exhibit distinct vasodilatory (ANP-DRD) and diuretic\/natriuretic (ANP-DGD) activities, and therefore have the potential to provide precision therapy for ADHF patients with differing pathophysiological derangement of pressure\u2013volume homeostasis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cvr\/cvaa052","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T20:25:29Z","timestamp":1583958329000},"page":"508-519","source":"Crossref","is-referenced-by-count":7,"title":["Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure"],"prefix":"10.1093","volume":"117","author":[{"given":"Miriam T","family":"Rademaker","sequence":"first","affiliation":[{"name":"Department of Medicine, Christchurch Heart Institute, University of Otago-Christchurch, PO Box 4345, Christchurch 8011, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola J A","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Medicine, Christchurch Heart Institute, University of Otago-Christchurch, PO Box 4345, Christchurch 8011, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0002-4603","authenticated-orcid":false,"given":"Cho Yeow","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Manjunatha","family":"Kini","sequence":"additional","affiliation":[{"name":"Department of Biological Science, Faculty of Science, National University of Singapore, Singapore 119228, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A Mark","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Medicine, Christchurch Heart Institute, University of Otago-Christchurch, PO Box 4345, Christchurch 8011, New Zealand"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore"},{"name":"Cardiovascular Research Institute, National University Health Systems, Centre for Translational Medicine, Medical Drive, Singapore 117599, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"2021021105161947700_cvaa052-B1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2021021105161947700_cvaa052-B2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0002-8703(00)90311-9","article-title":"Predictors of readmission among elderly survivors of admission with heart failure","volume":"139","author":"Krumholz","year":"2000","journal-title":"Am Heart J"},{"key":"2021021105161947700_cvaa052-B3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2021021105161947700_cvaa052-B4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1503\/cmaj.051620","article-title":"Management of acute decompensated heart failure","volume":"176","author":"Allen","year":"2007","journal-title":"Can Med Assoc J"},{"key":"2021021105161947700_cvaa052-B5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"2021021105161947700_cvaa052-B6","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0008-6363(96)00134-4","article-title":"Vascular effects of loop diuretics","volume":"32","author":"Dormans","year":"1996","journal-title":"Cardiovasc Res"},{"key":"2021021105161947700_cvaa052-B7","first-page":"813","article-title":"Reassessing treatment of acute heart failure syndromes: the ADHERE registry","volume":"7","author":"Gheorghiade","year":"2005","journal-title":"Eur Heart J"},{"key":"2021021105161947700_cvaa052-B8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/CS20040253","article-title":"Cardiac natriuretic peptides for cardiac health","volume":"108","author":"Rademaker","year":"2005","journal-title":"Clin Sci"},{"key":"2021021105161947700_cvaa052-B9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BCJ20170690","article-title":"Decoding the molecular switches of natriuretic peptides which differentiate its vascular and renal functions","volume":"475","author":"Sridharan","year":"2018","journal-title":"Biochem J"},{"key":"2021021105161947700_cvaa052-B10","first-page":"H1052","article-title":"Neurohumoral changes during the onset and offset of ovine heart failure: role of ANP","volume":"256","author":"Fitzpatrick","year":"1989","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B11","first-page":"H594","article-title":"Natriuretic peptide responses to acute and chronic pacing in sheep","volume":"270","author":"Rademaker","year":"1996","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B12","first-page":"R2040","article-title":"Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep","volume":"272","author":"Charles","year":"1997","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B13","first-page":"H1625","article-title":"Hemodynamic and hormonal effects of renin inhibition in ovine heart failure","volume":"258","author":"Fitzpatrick","year":"1990","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B14","first-page":"R1324","article-title":"Comparative bioactivity of atrial, brain and C-type natriuretic peptides in conscious sheep","volume":"270","author":"Charles","year":"1996","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/cs0920159","article-title":"Comparative bioactivity of atrial and brain natriuretic peptide in an ovine model of heart failure","volume":"92","author":"Rademaker","year":"1997","journal-title":"Clin Sci"},{"key":"2021021105161947700_cvaa052-B16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/00002018-200730090-00004","article-title":"Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure","volume":"30","author":"Yancy","year":"2007","journal-title":"Drug Saf"},{"key":"2021021105161947700_cvaa052-B17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/advan.00177.2016","article-title":"The renal and cardiovascular effects of natriuretic peptides","volume":"41","author":"Wong","year":"2017","journal-title":"Adv Physiol Educ"},{"key":"2021021105161947700_cvaa052-B18","first-page":"H2406","article-title":"Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart","volume":"273","author":"Yamamoto","year":"1997","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1540-8167.1993.tb01257.x","article-title":"Influence of ANP on sympathetic nerve activity and chronotropic regulation of the heart","volume":"4","author":"Imaizumi","year":"1993","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021021105161947700_cvaa052-B20","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1073\/pnas.83.13.4769","article-title":"Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process","volume":"83","author":"Kurtz","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021021105161947700_cvaa052-B21","first-page":"F863","article-title":"Effects of synthetic atrial natriuretic factor on renal function and renin release","volume":"247","author":"Burnett","year":"1984","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/312756a0","article-title":"Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor","volume":"312","author":"Kudo","year":"1984","journal-title":"Nature"},{"key":"2021021105161947700_cvaa052-B23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/324473a0","article-title":"Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney","volume":"324","author":"Marin-Grez","year":"1986","journal-title":"Nature"},{"key":"2021021105161947700_cvaa052-B24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s40138-014-0040-z","article-title":"Vasodilators in acute heart failure: review of the latest studies","volume":"2","author":"Levy","year":"2014","journal-title":"Curr Emerg Hosp Med Rep"},{"key":"2021021105161947700_cvaa052-B25","doi-asserted-by":"crossref","first-page":"e008545","DOI":"10.1136\/bmjopen-2015-008545","article-title":"Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials","volume":"6","author":"Gong","year":"2016","journal-title":"BMJ Open"},{"key":"2021021105161947700_cvaa052-B26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/107424840200700308","article-title":"Nesiritide: a new drug for the treatment of decompensated heart failure","volume":"7","author":"Elkayam","year":"2002","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2021021105161947700_cvaa052-B27","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/01.CIR.0000070547.88378.EA","article-title":"of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake","volume":"107","author":"Michaels","year":"2003","journal-title":"Circulation"},{"key":"2021021105161947700_cvaa052-B28","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1038\/ki.1995.474","article-title":"Natriuretic peptide receptors A and B have different cellular distributions in rat kidney","volume":"48","author":"Ritter","year":"1995","journal-title":"Kidney Int"},{"key":"2021021105161947700_cvaa052-B29","first-page":"F1047","article-title":"ANP-induced signaling cascade and its implications in renal pathophysiology","volume":"308","author":"Theilig","year":"2015","journal-title":"Am J Physiol"},{"key":"2021021105161947700_cvaa052-B30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1126\/science.2463673","article-title":"Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells","volume":"243","author":"Light","year":"1989","journal-title":"Science"},{"key":"2021021105161947700_cvaa052-B31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0272-6386(97)90476-5","article-title":"Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease","volume":"29","author":"Stockand","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"2021021105161947700_cvaa052-B32","first-page":"91","article-title":"Actions of atrial natriuretic peptides on the kidney","volume":"7","author":"Ziedel","year":"1987","journal-title":"Semin Nephrol"},{"key":"2021021105161947700_cvaa052-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-017-0093-0","article-title":"Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure","volume":"12","author":"Fu","year":"2018","journal-title":"J Biol Eng"},{"key":"2021021105161947700_cvaa052-B34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/326697a0","article-title":"Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption","volume":"326","author":"Harris","year":"1987","journal-title":"Nature"},{"key":"2021021105161947700_cvaa052-B35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1113\/jphysiol.2002.018390","article-title":"Effect of exogenous and endogenous angiotensin II on intrarenal distribution of glomerular filtration rate in rats","volume":"541","author":"Treeck","year":"2002","journal-title":"J Physiol"},{"key":"2021021105161947700_cvaa052-B36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11897-008-0024-y","article-title":"Rational use of diuretics in acute decompensated heart failure","volume":"5","author":"Goebel","year":"2008","journal-title":"Curr Heart Fail Rep"},{"key":"2021021105161947700_cvaa052-B37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"3","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"2021021105161947700_cvaa052-B38","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.CCM.0000296270.41256.5C","article-title":"Acute decompensated heart failure and the cardiorenal syndrome","volume":"36","author":"Liang","year":"2008","journal-title":"Crit Care Med"},{"key":"2021021105161947700_cvaa052-B39","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.73.Suppl_2.S8","article-title":"Acute decompensated heart failure: the cardiorenal syndrome","volume":"73","author":"Francis","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"2021021105161947700_cvaa052-B40","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1038\/s41598-017-10748-6","article-title":"A new chimeric natriuretic peptide, CNAAC, for the treatment of left ventricular dysfunction after myocardial infarction","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"2021021105161947700_cvaa052-B41","first-page":"557","article-title":"Innovative therapeutics: designer natriuretic peptides","volume":"1","author":"Meems","year":"2016","journal-title":"J Am Coll Cardiol Basic Transl Sci"},{"key":"2021021105161947700_cvaa052-B42","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3390\/ijms20112629","article-title":"Natriuretic peptides in heart failure with preserved left ventricular ejection fraction: from molecular evidences to clinical implications","volume":"20","author":"Tanase","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2021021105161947700_cvaa052-B43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jacc.2009.04.080","article-title":"A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions","volume":"54","author":"McKie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2021021105161947700_cvaa052-B44","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.118.314164","article-title":"CRRL269: a novel particulate guanylyl cyclase a receptor peptide activator for acute kidney injury","volume":"124","author":"Chen","year":"2019","journal-title":"Circ Res"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaa052\/33200194\/cvaa052.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/117\/2\/508\/36230927\/cvaa052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/117\/2\/508\/36230927\/cvaa052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T18:52:05Z","timestamp":1613155925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/117\/2\/508\/5804984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,13]]},"published-print":{"date-parts":[[2021,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaa052","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,3,13]]}}}